Anhui Huaheng Biotechnology Co. Ltd. A Net Asset Quality Index
Anhui Huaheng Biotechnology Co. Ltd. A net asset quality index. Anhui Huaheng Biotechnology Co. Ltd. A (688639) has a Net Asset Quality Index of 44.3% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥6.03 Billion minus total liabilities of CN¥3.36 Billion yields net assets of CN¥2.67 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See Anhui Huaheng Biotechnology Co. Ltd. A (688639) net assets for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Anhui Huaheng Biotechnology Co. Ltd. A (2012–2025)
Net asset quality index of Anhui Huaheng Biotechnology Co. Ltd. A from 2012 to 2025. This chart shows how Anhui Huaheng Biotechnology Co. Ltd. A's Net Asset Quality Index has evolved across 14 annual periods from 2012 to 2025. As of March 2026, the index stands at 44.3%, representing net assets of CN¥2.67 Billion against total assets of CN¥6.03 Billion CNY. Check 688639 tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Anhui Huaheng Biotechnology Co. Ltd. A Net Asset Quality Index by Year (2012–2025)
Anhui Huaheng Biotechnology Co. Ltd. A net asset quality index by year from 2012 to 2025. The table below presents the year-by-year Net Asset Quality Index for Anhui Huaheng Biotechnology Co. Ltd. A from 2012 to 2025, covering 14 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market value of Anhui Huaheng Biotechnology Co. Ltd. A.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 45.6% | CN¥2.63 Billion | CN¥5.77 Billion | CN¥3.14 Billion | ▼ -5.7 pp |
| 2024 | 51.3% | CN¥2.56 Billion | CN¥4.99 Billion | CN¥2.43 Billion | ▲ +5.3 pp |
| 2023 | 46.0% | CN¥1.83 Billion | CN¥3.97 Billion | CN¥2.14 Billion | ▼ -27.1 pp |
| 2022 | 73.1% | CN¥1.48 Billion | CN¥2.03 Billion | CN¥545.44 Million | ▼ -7.2 pp |
| 2021 | 80.3% | CN¥1.18 Billion | CN¥1.47 Billion | CN¥290.98 Million | ▲ +14.3 pp |
| 2020 | 65.9% | CN¥489.78 Million | CN¥742.89 Million | CN¥253.11 Million | ▲ +0.2 pp |
| 2019 | 65.7% | CN¥368.68 Million | CN¥561.09 Million | CN¥192.41 Million | ▲ +8.4 pp |
| 2018 | 57.3% | CN¥310.29 Million | CN¥541.13 Million | CN¥230.84 Million | ▲ +6.2 pp |
| 2017 | 51.1% | CN¥210.73 Million | CN¥412.06 Million | CN¥201.33 Million | ▲ +5.5 pp |
| 2016 | 45.7% | CN¥176.26 Million | CN¥386.04 Million | CN¥209.78 Million | ▲ +6.1 pp |
| 2015 | 39.6% | CN¥114.46 Million | CN¥289.20 Million | CN¥174.73 Million | ▲ +11.1 pp |
| 2014 | 28.5% | CN¥54.10 Million | CN¥189.91 Million | CN¥135.81 Million | ▲ +17.4 pp |
| 2013 | 11.1% | CN¥20.46 Million | CN¥184.98 Million | CN¥164.52 Million | ▲ +4.9 pp |
| 2012 | 6.2% | CN¥7.80 Million | CN¥125.90 Million | CN¥118.10 Million | — |